Our top pick for
Aware, Inc is a software-application business based in the US. Aware shares (AWRE) are listed on the NASDAQ and all prices are listed in US Dollars. Aware employs 90 staff and has a trailing 12-month revenue of around USD$11.3 million.
|52-week range||USD$2.02 - USD$6.52|
|50-day moving average||USD$4.4029|
|200-day moving average||USD$3.2701|
|Wall St. target price||USD$6|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.056|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Aware stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aware's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aware's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 44x. In other words, Aware shares trade at around 44x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Aware's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$692,000.
The EBITDA is a measure of a Aware's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$11.3 million|
|Gross profit TTM||USD$10.5 million|
|Return on assets TTM||-9.99%|
|Return on equity TTM||-15.37%|
|Market capitalisation||USD$100.8 million|
TTM: trailing 12 months
There are currently 26,692 Aware shares held short by investors – that's known as Aware's "short interest". This figure is 24.2% down from 35,201 last month.
There are a few different ways that this level of interest in shorting Aware shares can be evaluated.
Aware's "short interest ratio" (SIR) is the quantity of Aware shares currently shorted divided by the average quantity of Aware shares traded daily (recently around 56791.489361702). Aware's SIR currently stands at 0.47. In other words for every 100,000 Aware shares traded daily on the market, roughly 470 shares are currently held short.
However Aware's short interest can also be evaluated against the total number of Aware shares, or, against the total number of tradable Aware shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aware's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Aware shares in existence, roughly 0 shares are currently held short) or 0.0017% of the tradable shares (for every 100,000 tradable Aware shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aware.
Find out more about how you can short Aware stock.
We're not expecting Aware to pay a dividend over the next 12 months.
Over the last 12 months, Aware's shares have ranged in value from as little as $2.02 up to $6.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aware's is 0.2129. This would suggest that Aware's shares are less volatile than average (for this exchange).
Aware, Inc. provides software and services for the biometrics industry in the United States, the United Kingdom, Brazil, and internationally. It offers biometrics software products, including biometric search and matching software development kits (SDKs), biometric enrollment SDKs and application program interfaces (APIs), identity text analytics SDK ? Inquire, biometric services platform ? BioSP, and cluster-based matching platform ? Astra; and integrated solutions comprising Knomi, AwareABIS, WebEnroll, and Indigo, as well as biometric applications that enable various functions in biometrics systems, such as enrollment, analysis, and processing of biometric images and data on workstations or mobile devices; integration of peripheral biometric capture devices; centralized workflow, transaction processing, and subsystem integration; matching of biometric samples against biometric databases to authenticate or verify identities; and analysis and processing of text-based identity data. The company also provides imaging products for medical applications, such as JPEG2000 product to compress, store, and display images, as well as software maintenance services. In addition, it offers software engineering services comprising project planning and management; system design; software design, development, customization, configuration, and testing; and software integration and installation. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. It sells its biometrics software products and services through systems integrators, OEMs, value added resellers, and directly to end user customers. Aware, Inc. was founded in 1986 and is headquartered in Bedford, Massachusetts.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.